1-heterocyclylalkyl-3-sulfonyl-indole or -indazole...

Details 1-heterocyclylalkyl-3-sulfonyl-indole or -indazole... 1-heterocyclylalkyl-3-sulfonyl-indole or -indazole...

2006-02-07

2006-02-07

Chang, Celia (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C546S201000

Reexamination Certificate

active

06995176

ABSTRACT:
The present invention provides a compound of formula I and the use thereof for the treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor.

REFERENCES:
patent: 5567711 (1996-10-01), Sheppard et al.
patent: 6727246 (2004-04-01), Bernotas et al.
patent: 2005/0020575 (2005-01-01), Cole et al.
patent: WO97 49382 (1997-12-01), None
patent: WO97 49698 (1997-12-01), None
patent: WO97 49699 (1997-12-01), None
patent: WO03 013510A (2003-02-01), None
Allen et al. “Preparation of 4-heterocyclyl-1- . . . ”CA 128:102084 (1998).

Affiliated with

Also associated with

Rating

1-heterocyclylalkyl-3-sulfonyl-indole or -indazole... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 1-heterocyclylalkyl-3-sulfonyl-indole or -indazole..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1-heterocyclylalkyl-3-sulfonyl-indole or -indazole... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3707607